• Group
    • Companies
    • History
    • Business model
    • Mission and vision
    • Corporate values
    • Commitment to sport
  • Research
    • Pharmaceutical Research
    • Sucrosomial Technology
    • Cetylated Fatty Acids
    • Quality and certifications
  • Brands
    • PharmaNutra
    • Junia Pharma
    • Alesco
    • Akern
  • Investor
    • INVESTOR RELATIONS
      • Stock performance
      • Share capital and Shareholders
      • Shares study and research
      • Broker
      • Financial statements
      • Presentations
      • Corporate events
      • Company presentation
      • Notice of meetings
      • SDIR
      • AIM admission document
      • MTA prospectus
    • PRESS
      • Press releases
      • Press review
  • Governance
    • Code of Ethics
    • 231 Model
    • Board of Directors and Committees
    • Company documents
    • Internal dealing
    • Shareholders’ meeting
    • Statutory auditors and Audit firm
    • Sharholders Agreements
  • Sustainability
  • News
    • Science
    • Corporate
    • Events
    • Social commitment
  • Careers
    • Work with us
    • Job offers
    • Job application
  • Group
    • Companies
    • History
    • Business model
    • Mission and vision
    • Corporate values
    • Commitment to sport
  • Research
    • Pharmaceutical Research
    • Sucrosomial Technology
    • Cetylated Fatty Acids
    • Quality and certifications
  • Brands
    • PharmaNutra
    • Junia Pharma
    • Alesco
    • Akern
  • Investor
    • INVESTOR RELATIONS
      • Stock performance
      • Share capital and Shareholders
      • Shares study and research
      • Broker
      • Financial statements
      • Presentations
      • Corporate events
      • Company presentation
      • Notice of meetings
      • SDIR
      • AIM admission document
      • MTA prospectus
    • PRESS
      • Press releases
      • Press review
  • Governance
    • Code of Ethics
    • 231 Model
    • Board of Directors and Committees
    • Company documents
    • Internal dealing
    • Shareholders’ meeting
    • Statutory auditors and Audit firm
    • Sharholders Agreements
  • Sustainability
  • News
    • Science
    • Corporate
    • Events
    • Social commitment
  • Careers
    • Work with us
    • Job offers
    • Job application
  • it
  • en

26 May 2023

PHARMANUTRA S.P.A.: CETILAR® SIDE BY SIDE WITH FERNANDO ALONSO

08 May 2023

PHARMANUTRA S.P.A.: BOARD OF DIRECTORS APPROVES INTERIM REPORT TO 31 MARCH 2023

12 April 2023

PHARMANUTRA SIGNS THREE NEW AGREEMENTS FOR THE FOREIGN DISTRIBUTION OF SIDERAL® PRODUCTS

17 March 2023

PHARMANUTRA S.P.A: DEPOSITO DOCUMENTAZIONE PER ASSEMBLEA DEGLI AZIONISTI

16 March 2023

PHARMANUTRA: THE BOD APPROVES THE DRAFT FINANCIAL STATEMENTS AND THE CONSOLIDATED FINANCIAL STATEMENTS AS AT 31 DECEMBER 2022

Sorry, this entry is only available in Italian.:

21 February 2023

PHARMANUTRA THE STRATEGIC GUIDELINES FOR THE NEXT YEARS WERE PRESENTED AT THE INVESTOR’S DAY

08 February 2023

PHARMANUTRA PARTNERS WITH FERRARI TO FACE THE CHALLENGES OF THE NEW LE MANS HYPERCAR 499P

24 January 2023

INTEGRATION OF THE 2023 CORPORATE EVENTS CALENDAR

12 January 2023

PUBLICATION OF THE 2023 CORPORATE EVENTS CALENDAR

04 January 2023

NEW DISTRIBUTION AGREEMENTS IN INDONESIA, KUWAIT AND MEXICO

12 December 2022

NEW COMPANY PHARMANUTRA U.S.A. CORP. ESTABLISHED FOR DISTRIBUTION IN THE UNITED STATES

05 December 2022

PHARMANUTRA S.P.A. COMPLETES AKERN S.R.L. ACQUISITION

1 2 … 16 >

PharmaNutra Spa

Registered office

Via Delle Lenze, 216/b - 56122 Pisa

Phone +39 050 7846500

Fax +39 050 7846524

Electronic billing code

SUBM70N

C.F. / P.Iva / Reg. Impr. 01679440501

Share capital € 1.123.097,70

I.V. | REA 146259

Contacts

Info
info@pharmanutra.it
Commerciale
commerciale@pharmanutra.it
Investor relations
investorrelation@pharmanutra.it
Distribution
internationaldept@pharmanutra.it

Product sites

sideral.it

cetilar.it

ultramag.it

apportal.it

NEWSLETTER

Subscribe to the Pharmanutra newsletter and you will be constantly updated on all our activities.
Read Newsletter Disclosure

Subscribe to the newsletter
Privacy & Cookie policy Change cookie preferences General conditions PRIVACY INFORMATION FOR CUSTOMERS

© 2023 2020 PharmaNutra SpA - All rights reserved

Modifica preferenze Cookie
Modifica preferenze Cookie